World hip trauma evaluation five: a randomised controlled trial comparing cemented and uncemented implants for the treatment of displaced intracapsular hip fractures

Not Applicable

Completed

• Conditions: Hip fracture; Musculoskeletal Diseases; Fracture of neck of femur

• Registration Number: ISRCTN18393176
• Lead Sponsor: niversity of Oxford

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31822548/ protocol (added 01/12/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35139272/ (added 10/02/2022) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/33215102/ Economic evaluation plan (added 26/04/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-16
• Study Completion: 2021-01-31
• Last Update Posted: 8 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1125

Inclusion Criteria

Feasibility study:
All patients, both those with and without capacity, presenting with an AO type 31-B3 (subcapital, displaced, nonimpacted) fracture of the hip

Main phase of the study (added 11/04/2018):
All patients aged 60 years and older who have fractured their hip and will receive treatment with a hemiarthroplasty

Exclusion Criteria

1. Younger than 60 years of age
2. Managed non-operatively
3. Treated with a total hip replacement

Study & Design

• Study Type: Interventional
• Study Design: Not specified